Global Home Parenteral Nutrition (HPN) Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Home Parenteral Nutrition (HPN) Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Home parenteral nutrition (HPN) refers to long-term feeding methods that directly administer essential nutrients into the bloodstream via peripheral venous access devices like midlines, portacatheters, or implanted ports instead of eating and digesting ordinary foods orally.
Home Parenteral Nutrition (HPN) report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Home Parenteral Nutrition (HPN) market is projected to reach US$ 1219.5 million in 2029, increasing from US$ 804 million in 2022, with the CAGR of 6.2% during the period of 2024 to 2029. Demand from Neonates and Geriatrics are the major drivers for the industry.
The global Home Parenteral Nutrition (HPN) market has been growing steadily in recent years, driven primarily by advancements in technology and increased awareness about the benefits of HPN. However, there have also been challenges faced by companies operating within the space, including regulatory hurdles and competition from alternative forms of treatment.
The market growth can be attributed to rising incidence rates of malnutrition among patients suffering from chronic diseases such as cancer and liver failures, expanding geriatric population with fragile immune systems requiring external nutritional support, and favorable reimbursement scenarios in developed regions worldwide promoting wider adoption of HPN solutions.
The future outlook for the HPN market appears positive given the increasing number of indications covered by HPN, development of new products capable of addressing unmet needs, and strengthening partnerships between key players and third parties to foster better care pathway coordination across diverse territories with varying regulatory environments impacting product availability. With increasing emphasis placed on precision medicine approaches involving personalized nutrition.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Home Parenteral Nutrition (HPN) market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
Baxter
Takeda
Pfizer
B. Braun Melsungen
Grifols International
Fresenius Kabi
Otsuka Pharmaceutical
Teva Pharmaceutical
Sichuan Kelun Pharmaceutical
Segment by Type
Carbohydrates
Parenteral Lipid Emulsion
Single Dose Amino Acid Solution
Trace Elements
Vitamins and Minerals
Neonates
Geriatrics
Chronic Disease Patients
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Home Parenteral Nutrition (HPN) market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Home Parenteral Nutrition (HPN), product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Home Parenteral Nutrition (HPN) industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Home Parenteral Nutrition (HPN) in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Home Parenteral Nutrition (HPN) introduction, etc. Home Parenteral Nutrition (HPN) Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Home Parenteral Nutrition (HPN) market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.
Home Parenteral Nutrition (HPN) report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Home Parenteral Nutrition (HPN) market is projected to reach US$ 1219.5 million in 2029, increasing from US$ 804 million in 2022, with the CAGR of 6.2% during the period of 2024 to 2029. Demand from Neonates and Geriatrics are the major drivers for the industry.
The global Home Parenteral Nutrition (HPN) market has been growing steadily in recent years, driven primarily by advancements in technology and increased awareness about the benefits of HPN. However, there have also been challenges faced by companies operating within the space, including regulatory hurdles and competition from alternative forms of treatment.
The market growth can be attributed to rising incidence rates of malnutrition among patients suffering from chronic diseases such as cancer and liver failures, expanding geriatric population with fragile immune systems requiring external nutritional support, and favorable reimbursement scenarios in developed regions worldwide promoting wider adoption of HPN solutions.
The future outlook for the HPN market appears positive given the increasing number of indications covered by HPN, development of new products capable of addressing unmet needs, and strengthening partnerships between key players and third parties to foster better care pathway coordination across diverse territories with varying regulatory environments impacting product availability. With increasing emphasis placed on precision medicine approaches involving personalized nutrition.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Home Parenteral Nutrition (HPN) market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
Baxter
Takeda
Pfizer
B. Braun Melsungen
Grifols International
Fresenius Kabi
Otsuka Pharmaceutical
Teva Pharmaceutical
Sichuan Kelun Pharmaceutical
Segment by Type
Carbohydrates
Parenteral Lipid Emulsion
Single Dose Amino Acid Solution
Trace Elements
Vitamins and Minerals
Segment by Application
Neonates
Geriatrics
Chronic Disease Patients
Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Home Parenteral Nutrition (HPN) market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Home Parenteral Nutrition (HPN), product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Home Parenteral Nutrition (HPN) industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Home Parenteral Nutrition (HPN) in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Home Parenteral Nutrition (HPN) introduction, etc. Home Parenteral Nutrition (HPN) Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Home Parenteral Nutrition (HPN) market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices